MedPath

The effect of pessary usage in the treatment of prolapse of pelvic organs.

Phase 2
Conditions
Prolapse Of Pelvic Organs.
Prolapse Of Pelvic Organs
Registration Number
IRCT2016072618311N2
Lead Sponsor
Vice chancellor for Research,Tabriz University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Women with pelvic organ prolapse symptoms; Women between 40 to 80 years
Exclusion criteria:Patients with malignant problems of women; asthma; heart disease and risk for surgery

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rinary Symptoms. Timepoint: Before intervention; three months afte rintervention; three months afte rintervention. Method of measurement: Pelvic Organ Prolapse Quantification System (POP–Q).
Secondary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: Before treatment, three months and six months after treatment. Method of measurement: questionnaire (Incontinence quality of life =I-QOL).
© Copyright 2025. All Rights Reserved by MedPath